Hologic Highlights Automated Lab Solutions and Expansive Diagnostic Menu at AACC 2022

Hologic, Inc. (Marlborough, MA, USA) will be demonstrating how its automated solutions and expansive diagnostic menu can help laboratories grow at the 2022 AACC Clinical Lab Expo.

Hologic is highlighting its Panther Scalable Solutions that allow laboratories to expand their testing menu while adding on flexibility, capacity and walkaway time. The Panther system serves as the foundation of Hologic’s automation with the option to add on the Panther Fusion module, Panther Plus, Panther Link and Panther Trax. Panther Scalable Solutions provides laboratories an economical and scalable path to growth. Laboratories can select from a broad menu of Aptima and Panther Fusion assays that help guide patient care and enable early detection to run on scalable automation. With a menu and pipeline of world-class assays, laboratories can consolidate their molecular testing today and meet their growing needs tomorrow.

For instance, Hologic’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Novodiag RESP-4 molecular diagnostic test assays detect and differentiate four of the most prevalent respiratory viruses that can present with similar clinical symptoms: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (Flu A), influenza B (Flu B) and respiratory syncytial virus (RSV). The Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is a high-performance cartridge-based assay that runs on the fully automated high-throughput Panther Fusion system. The Novodiag RESP-4 assay runs on the Novodiag system, the fully automated molecular diagnostic solution that delivers on-demand testing for infectious disease and antimicrobial resistance.

Also to be featured at the event is Hologic’s ThinPrep processors which are intuitive, versatile, and scalable solutions for laboratories of all volumes. The portfolio offers reliable, best-in-class systems that help cytology labs automate their processes – decreasing the need for hands-on labor and increasing laboratory efficiencies. And because every sample is a patient, Hologic’s automated chain-of-custody technology delivers confidence in results without sacrificing productivity. The company’s ThinPrep Pap test is the first FDA-approved, liquid-based cytology option in cervical disease screening and remains the preferred choice in Pap testing in the US.

Hologic is also highlighting its range of collection devices that support a comprehensive testing portfolio for women's health and infectious disease and have been rigorously developed for highly accurate and reliable results. These include diagnostic collection devices and transfer tubes, direct load capture cap collection kit, direct load tube collection kit and the Aptima multi-test swab.
 

Related Links:
Hologic, Inc.